Company Profiles

driven by the PitchBook Platform

Aptinyx

Description

Developer of drugs for disorders of the brain and nervous system. The company specializes in the research and development of drugs for neuropathic pain, post-traumatic stress disorder, traumatic brain injuries and migraines. It has developed a platform for discovering compounds that work through modulation of the NMDA receptor to enhance pathways involved with nerve-cell communication.

2015

Founded

PRIVATE

Status

51-200

Employees

Series A

Latest Deal Type

$65M

Latest Deal Amount

$65M

Total Amount Raised

Description

Developer of drugs for disorders of the brain and nervous system. The company specializes in the research and development of drugs for neuropathic pain, post-traumatic stress disorder, traumatic brain injuries and migraines. It has developed a platform for discovering compounds that work through modulation of the NMDA receptor to enhance pathways involved with nerve-cell communication.

Website:

www.aptinyx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

1801 Maple Avenue Suite 4300 Evanston, IL 60201United States +1 (847) 871-0377
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aptinyx's full profile, request a free trial.

Aptinyx Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aptinyx Investors (21)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Adams Street PartnersPE/BuyoutMinority000 0000000 0000
Baxter VenturesCorporate Venture CapitalMinority000 0000000 0000
Beecken Petty O'Keefe & CompanyPE/BuyoutMinority000 0000000 0000
Druid BioVenturesVenture CapitalMinority000 0000000 0000
EcoR1 CapitalHedge FundMinority000 0000000 0000
Adams Street Partners PE/Buyout
Baxter Ventures Corporate Venture Capital
Beecken Petty O'Keefe & Company PE/Buyout
Druid BioVentures Venture Capital
EcoR1 Capital Hedge Fund

Aptinyx Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Joseph Moskal Ph.DChief Scientific Officer
Ashish KhannaChief Business Officer
Amin Khan Ph.DVice President, Chemistry Research & Development
David Houck Ph.DVice President, Drug Development Operations & Quality
Patricia AdamsVice President, Human Resources & Administration
Joseph Moskal Ph.D Chief Scientific Officer
Ashish Khanna Chief Business Officer
Amin Khan Ph.D Vice President, Chemistry Research & Development
David Houck Ph.D Vice President, Drug Development Operations & Quality
Patricia Adams Vice President, Human Resources & Administration

Aptinyx Board Members (4)

NameRepresentingRoleSinceContact
Info
Geeta Vemuri Ph.DBaxter VenturesVice President000 0000
James Topper Ph.DFrazier HealthcareManaging General Partner, Life Sciences000 0000
Liam Ratcliffe Ph.DNew Leaf Venture PartnersManaging Director & General Partner000 0000
Patrick EnrightLongitude CapitalCo-Founder & Managing Director000 0000
Geeta Vemuri Ph.D Vice President Baxter Ventures
James Topper Ph.D Managing General Partner, Life Sciences Frazier Healthcare
Liam Ratcliffe Ph.D Managing Director & General Partner New Leaf Venture Partners
Patrick Enright Co-Founder & Managing Director Longitude Capital
Request full access to PitchBook